Global left ventricular load in asymptomatic aortic stenosis: Covariates and prognostic implication (the SEAS trial)

Cardiovascular Ultrasound

Volumn 10, Issue 1, 2012, Pages

  Rieck, Åshild E ^a   Gerdts, Eva ^a,b   Lønnebakken, Mai Tone ^a,b   Bahlmann, Edda ^c   Cioffi, Giovanni ^d   Gohlke Bärwolf, Christa ^e   Ray, Simon ^f   Cramariuc, Dana ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d Villa Bianca Hospital   (Italy)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^f MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aortic valve stenosis; Echocardiography; Hypertension; Prognosis; Valvuloarterial impedance

Indexed keywords

EZETIMIBE PLUS SIMVASTATIN;

ADULT; AGED; AORTA STENOSIS; ARTICLE; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE LOAD; HEART WORK; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; ANTICHOLESTEREMIC AGENTS; AORTIC VALVE STENOSIS; AZETIDINES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SIMVASTATIN; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84868254855     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-10-43     Document Type: Article

References (37)

1. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). Rieck AE, Cramariuc D, Staal EM, Rossebo AB, Wachtell K, Gerdts E, J Hypertens 2010 28 377 383 10.1097/HJH.0b013e328332fa44 19844185
2. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Masuda C, Dohi K, Sakurai Y, Bessho Y, Fukuda H, Fujii S, Sugimoto T, Tanabe M, Onishi K, Shiraki K, et al. Cardiovasc Ultrasound 2011 9 31 10.1186/1476-7120-9-31 22087774
3. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P, J Am Coll Cardiol 2005 46 291 298 10.1016/j.jacc.2004.10. 081 16022957 (Pubitemid 40966858)
4. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. Herrmann S, Stork S, Niemann M, Lange V, Strotmann JM, Frantz S, Beer M, Gattenlohner S, Voelker W, Ertl G, Weidemann F, J Am Coll Cardiol 2011 58 402 412 10.1016/j.jacc.2011.02.059 21757118
5. Severe aortic stenosis and its association with hypertension: analysis of clinical and echocardiographic parameters. Linhartova K, Filipovsky J, Cerbak R, Sterbakova G, Hanisova I, Beranek V, Blood Press 2007 16 122 128 10.1080/08037050701343241 17612911 (Pubitemid 47050374)
6. Independent association of high blood pressure and aortic atherosclerosis: A population-based study. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O'Fallon WM, Gentile F, Whisnant JP, Wiebers DO, Seward JB, Circulation 2000 102 2087 2093 10.1161/01.CIR.102.17.2087 11044425
7. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Rieck AE, Cramariuc D, Boman K, Gohlke-Barwolf C, Staal EM, Lonnebakken MT, Rossebo AB, Gerdts E, Hypertension 2012 60 90 97 10.1161/HYPERTENSIONAHA.112.194878 22647889
8. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. Hachicha Z, Dumesnil JG, Pibarot P, J Am Coll Cardiol 2009 54 1003 1011 10.1016/j.jacc.2009.04.079 19729117
9. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Lancellotti P, Donal E, Magne J, Moonen M, O'Connor K, Daubert JC, Pierard LA, Heart 2010 96 1364 1371 10.1136/hrt.2009.190942 20483891
10. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M, JAmSocEchocardiogr 2009 22 1 23
11. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Rossebo AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi VA, et al. Am J Cardiol 2007 99 970 973 10.1016/j.amjcard.2006.10.064 17398194 (Pubitemid 46483289)
12. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Gerdts E, Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Barwolf C, Holme I, Kesaniemi YA, et al. Am J Cardiol 2010 106 1634 1639 10.1016/j.amjcard.2010. 07.042 21094366
13. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, et al. NEnglJMed 2008 359 1343 1356 10.1056/NEJMoa0804602
14. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, et al. J Hypertens 2009 27 2121 2158 10.1097/HJH.0b013e328333146d 19838131
15. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy). Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebo AB, Gerdts E, Am J Cardiol 2008 101 510 515 10.1016/j.amjcard.2007.09.100 18312768 (Pubitemid 351199446)
16. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Lund BP, Gohlke-Barwolf C, Cramariuc D, Rossebo AB, Rieck AE, Gerdts E, Am J Cardiol 2010 105 1456 1460 10.1016/j.amjcard.2009.12. 069 20451694
17. Recommendations for chamber quantification. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al. Eur J Echocardiogr 2006 7 79 108 10.1016/j.euje.2005.12.014 16458610 (Pubitemid 43257193)
18. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N, Am J Cardiol 1986 57 450 458 10.1016/0002-9149(86)90771-X 2936235 (Pubitemid 16119719)
19. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, De DO, Alderman MH, J Am Coll Cardiol 1992 20 1251 1260 10.1016/0735-1097(92)90385-Z 1401629
20. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH, J Am Coll Cardiol 1995 25 1056 1062 10.1016/0735-1097(94)00540-7 7897116
21. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB, J Am Coll Cardiol 1996 28 751 756 8772767 (Pubitemid 26288660)
22. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. JAmSocEchocardiogr 2005 18 1440 1463 (Pubitemid 41821197)
23. Assessment of aortic valve stenosis severity: a new Index based on the Energy Loss Concept. Garcia DPP, Dumesnil J, Sakr F, Durand LG, Circulation 2000 101 765 771 10.1161/01.CIR.101.7.765 10683350 (Pubitemid 30100083)
24. Overestimation" of catheter gradients by Doppler ultrasound in patients with aortic stenosis: a predictable manifestation of pressure recovery. Baumgartner HST, Niederberger J, Schima H, Maurer G, J Am Coll Cardiol 999 33 1655 1661
25. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy. Bahlmann E, Cramariuc D, Gerdts E, Gohlke-Baerwolf C, Nienaber CA, Eriksen E, Wachtell K, Chambers J, Kuck KH, Ray S, JACC Cardiovasc Imaging 2010 3 555 562 10.1016/j.jcmg.2009.11.019 20541709
26. Aortic root geometry in aortic stenosis patients (a SEAS substudy). Bahlmann E, Nienaber CA, Cramariuc D, Gohlke-Baerwolf C, Ray S, Devereux RB, Wachtell K, Kuck KH, Davidsen E, Gerdts E, Eur J Echocardiogr 2011 12 585 590 10.1093/ejechocard/jer037 21508001
27. Reproducibility of cardiac stroke volume estimated by Doppler echocardiography. Ihlen H, Endresen K, Myreng Y, Myhre E, Am J Cardiol 1987 59 975 978 10.1016/0002-9149(87)91137-4 3565287 (Pubitemid 17074246)
28. Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study). Gerdts E, Franklin S, Rieck A, Papademetriou V, Wachtell K, Nieminen M, Dahlof B, Devereux RB, Blood Press 2009 18 180 186 10.1080/08037050903047202 19562573
29. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D, Hypertension 2004 43 1239 1245 10.1161/01.HYP.0000128420.01881.aa 15123572 (Pubitemid 38691746)
30. Age- and gender-related ventricular-vascular stiffening: a community-based study. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA, Circulation 2005 112 2254 2262 10.1161/CIRCULATIONAHA.105.541078 16203909 (Pubitemid 41464567)
31. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Safar ME, Levy BI, Struijker-Boudier H, Circulation 2003 107 2864 2869 10.1161/01.CIR.0000069826.36125.B4 12796414 (Pubitemid 36705999)
32. Gender differences in the timing of arterial wave reflection beyond differences in body height. Gatzka CD, Kingwell BA, Cameron JD, Berry KL, Liang YL, Dewar EM, Reid CM, Jennings GL, Dart AM, J Hypertens 2001 19 2197 2203 10.1097/00004872-200112000-00013 11725164 (Pubitemid 33135242)
33. Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Marechaux S, Carpentier E, Six-Carpentier M, Asseman P, LeJemtel TH, Jude B, Pibarot P, Ennezat PV, Arch Cardiovasc Dis 2010 103 227 235 10.1016/j.acvd.2010.03.003 20656633
34. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, Wachtell K, Gerdts E, JACC Cardiovasc Imaging 2009 2 390 399 10.1016/j.jcmg.2008.12.021 19580719
35. Prognostic significance of valvuloarterial impedance and left ventricular longitudinal function in asymptomatic severe aortic stenosis involving three-cuspid valves. Zito C, Salvia J, Cusma-Piccione M, Antonini-Canterin F, Lentini S, Oreto G, Di Bella G, Montericcio V, Carerj S, Am J Cardiol 2011 108 1463 1469 10.1016/j.amjcard.2011.06.070 21872194
36. Valvuloarterial impedance does not improve risk stratification in low-ejection fraction, low-gradient aortic stenosis: results from a multicentre study. Levy F, Luc Monin J, Rusinaru D, Petit-Eisenmann H, Lelguen C, Chauvel C, Adams C, Metz D, Leleu F, Gueret P, Tribouilloy C, Eur J Echocardiogr 2011 12 358 363 10.1093/ejechocard/jer022 21555457
37. Valvuloarterial impedance in aortic stenosis: look at the load, but do not forget the flow. Lancellotti P, Magne J, Eur J Echocardiogr 2011 12 354 357 10.1093/ejechocard/jer044 21555456